# Quasi-Steady-State Analysis based on Structural Modules and Timed Petri Net Predict System’s Dynamics: The Life Cycle of the Insulin Receptor

^{1}

^{2}

^{*}

## Abstract

**:**

## 1. Introduction

**Figure 1.**The processes of insulin-dependent activation and recycling of the IR. First, insulin binds to the IR. Afterwards, the IR gets autophosphorylated. Two alternative processes describe the dephosphorylation of the IR: (1) The IR can dephosphorylate on the plasma membrane by the dissociation of insulin; (2) The IR can be internalized into the cytoplasm. There, the insulin is degraded, and the IR is transported back to the plasma membrane. The processes of dephosphorylation on the plasma membrane and in the cytoplasm are both catalyzed by the enzyme PTP1B.

**Figure 2.**The PN describes the topological network structure of insulin dependent activation and recycling. Rectangles represent transitions, i.e., reactions. Places are plotted as circles. Directed, weighted edges connect transitions and places. The places represent chemical species, e.g., insulin, receptors, or complexes, and can carry tokens, which represent discrete amounts of the chemical species. Transitions can consume tokens from the pre-places and generate tokens on the post-places.

## 2. Methods

#### 2.1. Petri Nets

- P is a finite set of places,
- T is a finite set of transitions,
- $F\subseteq (P\times T)\cup (P\times T)$ is a set of edges,
- $W:F\to \mathbb{N}$ is the set of edge weights, and
- ${M}_{0}:P\to {\mathbb{N}}_{0}$ is the initial marking.

#### 2.1.1. Timed Petri Nets

**Figure 3.**An example for a TPN. The TPN consists of three places, place 1, place 2, and a time generation place (TGP), and one transition connected by directed edges with an edge of weight 1. (

**a**) In the initial state of the TPN, place 2 carries no token and place 1 10 tokens, each of them with a time stamp of $@0$. There exists a global clock time (not explicitly depicted) which is in the initial state 0. For the transition, a time delay of @ + 2 is defined, indicating that the time stamp of each token processed by this transition increases by 2. The TGP is a pre- and post-place of the transition, i.e., the token on that place will not be consumed when the transition fires. This token is initialized with a time stamp of $@0$. (${1}^{\prime}\left(\right)$ and ${1}^{\prime}\left[1\right]$ are specific notations of the CPN Tools.); (

**b**) The state of the TPN after four simulation steps. 4 tokens on place 1 were consumed and produced on place 2, carrying the time stamps, $@2,@4,@6$, and $@8$, respectively. The other six tokens remain still on place 1 with a time stamp of zero. The transition is enabled if on place 1 and the TGP exist at least one token with a time stamp less or equals the global clock time. If there is no transition activated anymore, the global clock time will be increased until at least one transition can fire. Here, the global clock time has to be increased by 2 with each firing step. The TGP ensures that the tokens can be distinguished from each other, i.e., only one token is moved from place 1 to place 2 for a given global clock time. After the first firing step, the time stamp of the TGP token and the token on place 2 have a time stamp of 2. The global clock time is still 0. Now, the transition is not anymore enabled, because there is no token with a time stamp less than or equals the global clock time on the TGP. For the next firing, the global clock time has to be increased by 2.

#### 2.1.2. General Properties

#### 2.1.3. Invariant Properties

## 3. Results and Discussion

**Table 1.**List of abbreviations and initial concentrations. Initial concentrations are adopted from Sedaghat et al. [34]. The concentrations are given in units of pM $={10}^{-12}\phantom{\rule{0.277778em}{0ex}}$M.

Abbreviation | Species | Initial Concentration(s) [pM] |
---|---|---|

I | insulin | [I]${}_{0}={10}^{3}$–${10}^{6}$ |

IR | insulin receptor | [IR]${}_{0}=0.9$ |

IRI | I-IR complex | — |

IRIP | phosphorylated IRI | — |

IRIP${}_{in}$ | intracellular IRIP | — |

IR${}_{in}$ | intracellular IR | [IR${}_{in}$]${}_{0}=0.1$ |

Parameter | Process | Value | Units |
---|---|---|---|

${k}_{\text{bind}}$ | binding of insulin | $6\times {10}^{7}$ | M${}^{-1}$ min${}^{-1}$ |

${k}_{\text{diss}}$ | dissociation of insulin | $0.2$ | min${}^{-1}$ |

${k}_{\text{phos}}$ | phosphorylation | $2.500$ | min${}^{-1}$ |

${k}_{\text{dephos,m}}$ | dephosphorylation on membrane | $0.2$ | min${}^{-1}$ |

${k}_{\text{in}}$ | internalization of IR | $3.\overline{3}\times {10}^{-4}$ | min${}^{-1}$ |

${k}_{\text{out}}$ | transport of IR to plasma membrane | $3\times {10}^{-3}$ | min${}^{-1}$ |

${k}_{\text{in,p}}$ | internalization of phosphorylated IR | $2.1\times {10}^{-3}$ | min${}^{-1}$ |

${k}_{\text{out,p}}$ | transport of phosphorylated IR to plasma membrane | $2.1\times {10}^{-4}$ | min${}^{-1}$ |

${k}_{\text{dephos,c}}$ | dephosphorylation in cytoplasm | $0.461$ | min${}^{-1}$ |

${k}_{\text{deg}}$ | degradation | $1.67\times {10}^{-4}$ | min${}^{-1}$ |

${k}_{\text{syn}}$ | synthesis | ${}^{*1}$ $1.67\times {10}^{-17}$ | M min${}^{-1}$ |

${}^{*2}$ $1.00\times {10}^{-16}$ | M min${}^{-1}$ |

#### 3.1. The P/T-PN Model and Its Properties

**Figure 4.**The transition invariant, TI${}_{1}$, is highlighted in the PN. TI${}_{1}$ describes a cycle of the processes: binding of insulin to the IR (${k}_{\text{bind}}$), phosphorylation of the insulin-IR complex (${k}_{\text{phos}}$), and extracellular dissociation of the activated insulin-IR complex (${k}_{\text{dephos,m}}$). The steady state of this subnetwork has an equilibrium constant of ${i}_{c}=3.33$ nM for the binding of insulin to the receptor.

**Figure 5.**The transition invariant, TI${}_{2}$, is highlighted in the PN. The six transitions of TI${}_{2}$ form a chain of six consecutive reactions: buffering of insulin (buffer), binding of insulin to the IR (${k}_{\text{bind}}$), phosphorylation of the insulin-IR complex (${k}_{\text{phos}}$), internalization of the activated insulin-IR complex (${k}_{\text{in,p}}$), dephosphorylation of the internalized insulin-IR complex (${k}_{\text{dephos,c}}$), and translocation of internalized IR back to the membrane (${k}_{\text{out}}$).

#### 3.2. The TPN Model and Its Properties

**Figure 6.**The TPN model of activation and recycling of the IR. It explicitly includes the enzyme, protein-tyrosine phosphatase 1B (PTP1B), see Figure 1 for a sketch of the catalytic function of PTPN1B. The circles represent chemical species, here, mainly the different insulin complexes, see Table 3. The rectangles describe the transitions, see Table 4. For a full list of places and transitions of the TPN, we refer to Table 3 and Table 4, respectively.

Name | Molecule | Initial Number of Tokens |
---|---|---|

I | insulin | 10,000 |

IR | insulin receptor | 90 |

IRI | I–IR complex | 0 |

IRIP | phosphorylated IRI | 0 |

IRIP${}_{intra}$ | intracellular IRIP | 0 |

IR${}_{intra}$ | intracellular IR | 10 |

PTPN1B | protein-tyrosine phosphatase 1B | 1000 |

IRIP PTP1B | IRIP–PTPN1B complex | 0 |

IRIP${}_{intra}$ PTPN1B | IRIP${}_{intra}$–PTPN1B complex | 0 |

Phos | phosphate | 1000 |

**Table 4.**List of transitions of the TPN model of receptor phosphorylation and recycling. The time inscriptions of the transitions are constant delay increments. We adapted the values of the constant delays to each initial insulin concentration of $1\phantom{\rule{0.166667em}{0ex}}\mu $M, $100\phantom{\rule{0.166667em}{0ex}}$nM, 10 nM, and $10\phantom{\rule{0.166667em}{0ex}}$nM separately. This list exemplifies the constant delays for ${i}_{0}=1\phantom{\rule{0.166667em}{0ex}}\mu $M.

Name | Process | Time Inscription |
---|---|---|

bin_1 | binding of insulin | @ + 1 |

dis_1 | dissociation of insulin | @ + 40 |

autophos_1 | phosphorylation of IRI | @ + 1 |

intra_1 | internalization of IR | @ + 200 |

memb_1 | transport of IR${}_{intra}$ to plasma membrane | @ + 85 |

intra_2 | internalization of IRIP | @ + 110 |

memb_2 | transport of IRIP${}_{intra}$ to plasma membrane | @ + 400 |

dephos_1 | dephosphorylation of IRIP by PTPN1B | @ + 1 |

dephos_2 | IRIP binds to PTPN1B | @ + 40 |

dephos_3 | IRIP${}_{intra}$ binds to PTPN1B | @ + 20 |

dephos_4 | dephosphorylation of IRIP${}_{intra}$ by PTPN1B | @ + 1 |

**Table 5.**Adaption of time delays of timed transitions to initial concentrations of insulin, 1 μM, 100 nM, 10 nM, and 1 nM. The values in parentheses are applied after 4500 and $15,000$ clock times for the insulin concentrations, ${i}_{0}=10$ nM and ${i}_{0}=1$ nM, respectively.

Transition | 1 μM | 100 nM | 10 nM | 1 nM |
---|---|---|---|---|

bin_1 | @ + 1 | @ + 7 | @ + 16 (@ + 29) | @ + 20 (@ + 30) |

dis_1 | @ + 40 | @ + 40 | @ + 40 (@ + 39) | @ + 40 (@ + 60) |

memb_1 | @ + 85 | @ + 85 | @ + 86 | @ + 86 |

intra_2 | @ + 110 | @ + 110 | @ + 119 | @ + 119 |

dephos_2 | @ + 40 | @ + 40 | @ + 40 (@ + 52) | @ + 40 (@ + 65) |

**Figure 7.**The left part depicts the concentrations of the IR (dark blue line), the phosphorylated insulin-IR complex IRIP (light blue line), the internalized complex IRIP${}_{intra}$ (purple line), and the intracellular IR${}_{intra}$ (yellow line) versus reaction time for initial insulin concentrations, 10 nM (part A, top), and 1 nM (part B, bottom), respectively. The concentrations are precise numerical simulations of the reaction system Equation (5). The right part shows the number of tokens versus the global clock time for the corresponding TPN. One token equates to a concentration of about 10 fM, and 2000 counts of the global clock time represent one minute reaction time.

#### 3.3. Quasi-Steady-State Approximation

**Figure 8.**The fractions of the steady-state concentrations, $i{r}^{*}/i{r}_{0}$ and $iri{p}^{*}/i{r}_{0}$, are plotted versus the concentration of the external insulin. The vertical line indicates the value of the equilibrium constant, ${i}_{c}=3.33$ nM. For insulin concentration above ${i}_{c}$, more than 50% of the extracellular IR binds an insulin molecule. All the IR becomes saturated for an insulin concentration which is large compared to ${i}_{c}$, i.e., for $i\gg {i}_{c}=3.33$ nM.

#### Time Behavior

**Figure 9.**Precise numerical solutions for the concentration of accessible IR on the membrane (solid line with the label free receptor), the total concentration of IR on the membrane, $i{r}_{memb}=ir+iri+irip$ (solid line with the label receptor (membrane)), and the total concentration of the IR, $i{r}_{tot}=i{r}_{memb}+iri{p}_{in}+i{r}_{in}$ (solid line with the label receptor (total)), are plotted versus the logarithmic time axis. The concentrations are given in percentage of the total concentration, $i{r}_{tot}$, of the IR of the basal cell. The initial insulin concentration is ${i}_{0}=1$ nM. The down-regulation of the cell for insulin given in excess passes through three phases: binding of insulin, internalization of the activated IR, and degradation of the IR inside the cell. The analytical approximation (Equation 6) for the concentration of the IR is drawn as dotted line with the label TI${}_{1}$ and describes the fast binding of insulin to the IR. The dotted line with the label TI${}_{2}$ shows the approximation (8). The analytical solution (Equation 11) for the concentration of the IR is depicted as dotted line with the label, TI${}_{2}$ + TI${}_{6}$, and is indistinguishable from the precise numerical solution (solid line free receptor) until the QSSA breaks down, i.e., until the consumption of insulin becomes measurable. The concentration of insulin is not plotted.

## 4. Conclusions

**Figure 10.**The steady-state concentrations, $i{r}^{\u2020}$ (red line), $iri{p}^{\u2020}$ (green line), $i{r}_{in}^{\u2020}$ (blue line), and $i{r}_{tot}=i{r}^{\u2020}+iri{p}^{\u2020}+i{r}_{in}^{\u2020}$ (violet line) are plotted versus the external insulin concentration ${i}_{0}$. The critical insulin concentration, ${i}_{c}^{\u2020}=0.535$ nM, and the equilibrium constant, ${i}_{c}=3.33$ nM, are indicated by left and right vertical lines, respectively. The steady-state concentration, $i{r}_{in}^{\u2020}$, is regulated by synthesis and degradation of the IR in the cytoplasm and hence, remains constant. The steady-state concentration, $iri{p}^{\u2020}$, is zero in the basal state of the cell, i.e., in absence of extracellular insulin, ${i}_{0}=0$. In the process of down-regulation of the cell, i.e., for increasing insulin level, ${i}_{0}$, the concentration, $iri{p}^{\u2020}$, increases until it reaches its maximal values for ${i}_{0}\gg {i}_{c}^{\u2020}$. The steady-state concentration, $i{r}^{\u2020}$, of the surface IR is maximal in the basal state and drops down to zero for ${i}_{0}\gg {i}_{c}^{\u2020}$.

## Supplementary Materials

## Acknowledgments

## Author Contributions

## Conflicts of Interest

## References

- Reaven, G.M. Role of insulin resistance in human disease. Diabetes
**1988**, 37, 1595–1607. [Google Scholar] [CrossRef] [PubMed] - López-Otín, C.; Blasco, M.A.; Partridge, L.; Serrano, M.; Kroemer, G. The hallmarks of aging. Cell
**2013**, 153, 1194–1217. [Google Scholar] [CrossRef] [PubMed] - Cohen, E.; Dillin, A. The insulin paradox: Aging, proteotoxicity and neurodegeneration. Nat. Rev. Neurosci.
**2008**, 9, 759–767. [Google Scholar] [CrossRef] [PubMed] - Schäffer, L. A model for insulin binding to the insulin receptor. Eur. J. Biochem.
**1994**, 221, 1127–1132. [Google Scholar] [CrossRef] [PubMed] - Subramanian, K.; Fee, C.J.; Fredericks, R.; Stubbs, R.S.; Hayes, M.T. Insulin receptor-insulin interaction kinetics using multiplex surface plasmon resonance. J. Mol. Recognit.
**2013**, 26, 643–652. [Google Scholar] [CrossRef] [PubMed] - Menting, J.G.; Whittaker, J.; Margetts, M.B.; Whittaker, L.J.; Kong, G.K.W.; Smith, B.J.; Watson, C.J.; Žáková, L.; Kletvíková, E.; Jirácek, J.; et al. How insulin engages its primary binding site on the insulin receptor. Nature
**2013**, 493, 241–245. [Google Scholar] [CrossRef] [PubMed] - Saltiel, A.; Kahn, R. Insulin signalling and the regulation of glucose and lipid metabolism. Nature
**2001**, 414, 799–806. [Google Scholar] [CrossRef] [PubMed] - Bouzakri, K.; Koistinen, H.; Zierath, J. Molecular mechanisms of skeletal muscle insulin resistance in type 2 diabetes. Curr. Diabetes Rev.
**2005**, 1, 167–174. [Google Scholar] [CrossRef] [PubMed] - Duckworth, W.C.; Bennett, R.G.; Hamel, F.G. Insulin degradation: Progress and potential. Endocr. Rev.
**1998**, 19, 608–624. [Google Scholar] [CrossRef] [PubMed] - Thorsøe, K.; Schlein, M.; Steensgaard, D.; Brandt, J.; Schluckebier, G.; Naver, H. Kinetic evidence for the sequential association of insulin binding site 1 and 2 to the insulin receptor and the influence of receptor isoform. Biochemistry
**2010**, 49, 6234–6246. [Google Scholar] [CrossRef] [PubMed] - De Meyts, P.; Roth, J.; Neville, D.M., Jr.; Gavin, J.R., III; Lesniak, M.A. Insulin interactions with its receptors: Experimental evidence for negative cooperativity. Biochem. Biophys. Res. Commun.
**1973**, 55, 154–161. [Google Scholar] [CrossRef] - Winter, P.W.; McPhee, J.T.; van Orden, A.K.; Roess, D.A.; Barisas, B.G. Fluorescence correlation spectroscopic examination of insulin and insulin-like growth factor 1 binding to live cells. Biophys. Chem.
**2011**, 159, 303–310. [Google Scholar] [CrossRef] [PubMed] - Hua, Q. Insulin: A small protein with a long journey. Protein Cell
**2010**, 1, 537–551. [Google Scholar] [CrossRef] [PubMed] - Ward, C.W.; Menting, J.G.; Lawrence, M.C. The insulin receptor changes conformation in unforeseen ways on ligand binding: Sharpening the picture of insulin receptor activation. BioEssays
**2013**, 35, 945–954. [Google Scholar] [CrossRef] [PubMed] - Corin, R.; Donner, D. Insulin receptors convert to a higher affinity state subsequent to hormone binding. A two-state model for the insulin receptor. J. Biol. Chem.
**1982**, 257, 104–110. [Google Scholar] [PubMed] - Jeffrey, P. The interaction of insulin with its receptor: Cross-linking via insulin association as the source of receptor clustering. Diabetologia
**1982**, 23, 381–385. [Google Scholar] [CrossRef] [PubMed] - Kohanski, R. Insulin receptor autophosphorylation. I. Autophosphorylation kinetics of the native receptor and its cytoplasmic kinase domain. Biochemistry
**1993**, 32, 5766–5772. [Google Scholar] [CrossRef] [PubMed] - Hammond, B.J.; Tikerpae, J.; Smith, G.D. An evaluation of the cross—Linking model for the interaction of insulin with its receptor. Am. J. Physiol. Endocrinol. Metab.
**1997**, 272, E1136–E1144. [Google Scholar] - Wanant, S.; Quon, M.J. Insulin receptor binding kinetics: Modeling and simulation studies. J. Theor. Biol.
**2000**, 205, 355–364. [Google Scholar] [CrossRef] [PubMed] - Kiselyov, V.; Versteyhe, S.; Gauguin, L.; de Meyts, P. Harmonic oscillator model of the insulin and IGF1 receptors allosteric binding and activation. Mol. Syst. Biol.
**2009**, 5, 1–12. [Google Scholar] [CrossRef] [PubMed] - Louise, K.; Pierre, D.M.; Vladislav, V.K. Insight into the molecular basis for the kinetic differences between the two insulin receptor isoforms. Biochem. J.
**2011**, 440, 397–403. [Google Scholar] - Desbuquois, B.; Lopez, S.; Burlet, H. Ligand-induced translocation of insulin receptors in intact rat liver. J. Biol. Chem.
**1982**, 257, 10852–10860. [Google Scholar] [PubMed] - Giudice, J.; Jares-Erijman, E.A.; Leskow, F.C. Endocytosis and intracellular dissociation rates of human insulin-insulin receptor complexes by quantum dots in living cells. Bioconjug. Chem.
**2013**, 24, 431–442. [Google Scholar] [CrossRef] [PubMed] - Amaya, M.J.; Oliveira, A.G.; Guimarães, E.S.; Casteluber, M.C.; Carvalho, S.M.; Andrade, L.M.; Pinto, M.C.; Mennone, A.; Oliveira, C.A.; Resende, R.R.; et al. The insulin receptor translocates to the nucleus to regulate cell proliferation in liver. Hepatology
**2014**, 59, 274–283. [Google Scholar] [CrossRef] [PubMed] - Chang, M.; Kwon, M.; Kim, S.; Yunn, N.O.; Kim, D.; Yunn, N.-O.; Kim, D.; Ryu, S.H.; Lee, J.-B. Aptamer-based single-molecule imaging of insulin receptors in living cells. J. Biomed. Opt.
**2013**, 19, 051204–051204. [Google Scholar] [CrossRef] [PubMed] - Fagerholm, S.; Örtegren, U.; Karlsson, M.; Ruishalme, I.; Strålfors, P. Rapid insulin-dependent endocytosis of the insulin receptor by caveolae in primary adipocytes. PLoS ONE
**2009**, 4, e5985. [Google Scholar] [CrossRef] [PubMed] [Green Version] - Makroglou, A.; Li, J.; Kuang, Y. Mathematical models and software tools for the glucose-insulin regulatory system and diabetes: An overview. Appl. Numer. Math.
**2006**, 56, 559–573. [Google Scholar] [CrossRef] - Standaert, M.; Pollet, R. Equilibrium model for insulin-induced receptor down-regulation. regulation of insulin receptors in differentiated BC3H-1 myocytes. J. Biol. Chem.
**1984**, 259, 2346–2354. [Google Scholar] [PubMed] - Backer, J.M.; Kahn, C.R.; White, M. Tyrosine phosphorylation of the insulin receptor during insulin-stimulated internalization in rat hepatoma cells. J. Biol. Chem.
**1989**, 264, 1694–1701. [Google Scholar] [PubMed] - Sturis, J.; Polonsky, K.S.; Mosekilde, E.; van Cauter, E. Computer model for mechanisms underlying ultradian oscillations of insulin and glucose. Am. J. Physiol. Endocrinol. Metab.
**1991**, 260, E801–E809. [Google Scholar] - Quon, M.J.; Campfield, L.A. A mathematical model and computer simulation study of insulin receptor regulation. J. Theor. Biol.
**1991**, 150, 59–72. [Google Scholar] [CrossRef] - Shymko, R.; Dumont, E.; de Meyts, P.; Dumont, J. Timing-dependence of insulin-receptor mitogenic versus metabolic signalling: A plausible model based on coincidence of hormone and effector binding. Biochem. J.
**1999**, 339, 675–683. [Google Scholar] [CrossRef] [PubMed] - Tolić, I.; Mosekilde, E.; Sturis, J. Modeling the insulin-glucose feedback system: The significance of pulsatile insulin secretion. J. Theor. Biol.
**2000**, 207, 361–375. [Google Scholar] [CrossRef] [PubMed] - Sedaghat, A.R.; Sherman, A.; Quon, M.J. A mathematical model of metabolic insulin signaling pathways. Am. J. Physiol. Endocrinol. Metab.
**2002**, 283, E1084–E1101. [Google Scholar] [CrossRef] [PubMed] - Giri, L.; Mutalik, V.K.; Venkatesh, K. A steady state analysis indicates that negative feedback regulation of PTP1B by Akt elicits bistability in insulin-stimulated GLUT4 translocation. Theor. Biol. Med. Model.
**2004**, 1, 2. [Google Scholar] [CrossRef] [PubMed] [Green Version] - Hori, S.S.; Kurland, I.J.; DiStefano, J.J., III. Role of endosomal trafficking dynamics on the regulation of hepatic insulin receptor activity: Models for Fao cells. Ann. Biomed. Eng.
**2006**, 34, 879–892. [Google Scholar] [CrossRef] [PubMed] - Koschorrek, M.; Gilles, E. Mathematical modeling and analysis of insulin clearance in vivo. BMC Syst. Biol.
**2008**, 2, 1–18. [Google Scholar] [CrossRef] [PubMed] - Liu, W.; Tang, F. Modeling a simplified regulatory system of blood glucose at molecular levels. J. Theor. Biol.
**2008**, 252, 608–620. [Google Scholar] [CrossRef] [PubMed] - Cedersund, G.; Roll, J.; Ulfhielm, E.; Danielsson, A.; Tidefelt, H.; Strålfors, P. Model-based hypothesis testing of key mechanisms in initial phase of insulin signaling. PLoS Comput. Biol.
**2008**, 4, e1000096. [Google Scholar] [CrossRef] [PubMed] - Cedersund, G.; Roll, J. Systems biology: Model based evaluation and comparison of potential explanations for given biological data. FEBS J.
**2009**, 276, 903–922. [Google Scholar] [CrossRef] [PubMed] - Liu, W.; Hsin, C.; Tang, F. A molecular mathematical model of glucose mobilization and uptake. Math. Biosci.
**2009**, 221, 121–129. [Google Scholar] [CrossRef] [PubMed] - Chew, Y.H.; Shia, Y.L.; Lee, C.T.; Majid, F.A.A.; Chua, L.S.; Sarmidi, M.R.; Aziz, R.A. Modeling of glucose regulation and insulin-signaling pathways. Mol. Cell. Endocrinol.
**2009**, 303, 13–24. [Google Scholar] [CrossRef] [PubMed] - Sogaard, P.; Szekeres, F.; Garcia-Roves, P.; Larsson, D.; Chibalin, A.; Zierath, J.R. Spatial insulin signalling in isolated skeletal muscle preparations. J. Cell. Biochem.
**2010**, 109, 943–949. [Google Scholar] [CrossRef] [PubMed] - Brännmark, C.; Palmér, R.; Glad, S.T.; Cedersund, G.; Strålfors, P. Mass and information feedbacks through receptor endocytosis govern insulin signaling as revealed using a parameter-free modeling framework. J. Biol. Chem.
**2010**, 285, 20171–20179. [Google Scholar] [CrossRef] [PubMed] - Nyman, E.; Brännmark, C.; Palmér, R.; Brugård, J.; Nyström, F.H.; Cedersund, G.; Strålfors, P. A hierarchical wholebody modeling approach elucidates the link between in vitro insulin signaling and in vivo glucose homeostasis. J. Biol. Chem.
**2011**, 286, 26028–26041. [Google Scholar] [CrossRef] [PubMed] - Nyman, E.; Cedersund, G.; Strålfors, P. Insulin signaling-mathematical modeling comes of age. Trends Endocrinol. Metab.
**2012**, 23, 107–115. [Google Scholar] [CrossRef] [PubMed] - Cedersund, G. Conclusions via unique predictions obtained despite unidentifiability-new definitions and a general method. FEBS J.
**2012**, 279, 3513–3527. [Google Scholar] [CrossRef] [PubMed] - Berestovsky, N.; Zhou, W.; Nagrath, D.; Nakhleh, L. Modeling integrated cellular machinery using hybrid Petri-Boolean networks. PLoS Comput. Biol.
**2013**, 9, e1003306. [Google Scholar] [CrossRef] [PubMed] - Garcia-Gabin, W.; Jacobsen, E.W. Multilevel model of type 1 diabetes mellitus patients for model-based glucose controllers. J. Diabetes Sci. Technol.
**2013**, 7, 193–201. [Google Scholar] [CrossRef] [PubMed] - Brännmark, C.; Nyman, E.; Fangerholm, S.; Bergenholm, L.; Ekstrand, E.M.; Cedersund, G.; Strålfors, P. Insulin signaling in type 2 diabetis. J. Biol. Chem.
**2013**, 288, 9876–9880. [Google Scholar] - Smith, G.R.; Shanley, D.P. Computational modelling of the regulation of insulin signalling by oxidative stress. BMC Syst. Biol.
**2013**, 7, 41. [Google Scholar] [CrossRef] [PubMed] - Ajmera, I.; Swat, M.; Laibe, C.; le Novère, N.; Chelliah, V. The impact of mathematical modeling on the understanding of diabetes and related complications. CPT Pharmacomet. Syst. Pharmacol.
**2013**, 2, e54. [Google Scholar] [CrossRef] [PubMed] - Bevan, A.P.; Drake, P.G.; Bergeron, J.J.; Posner, B.I. Intracellular signal transduction: The role of endosomes. Trends Endocrinol. Metab.
**1996**, 7, 13–21. [Google Scholar] [CrossRef] - Goh, L.K.; Sorkin, A. Endocytosis of receptor tyrosine kinases. Cold Spring Harb. Perspect. Biol.
**2013**, 5, a017459. [Google Scholar] [CrossRef] [PubMed] - Song, R.; Peng, W.; Zhang, Y.; Lv, F.; Wu, H.K.; Guo, J.; Cao, Y.; Pi, Y.; Zhang, X.; Jin, L.; et al. Central role of E3 ubiquitin ligase MG53 in insulin resistance and metabolic disorders. Nature
**2013**, 494, 375–379. [Google Scholar] [CrossRef] [PubMed] - Olefsky, J.M. Decreased insulin binding to adipocytes and circulating monocytes from obese subjects. J. Clin. Investig.
**1976**, 57, 1165–1172. [Google Scholar] [CrossRef] [PubMed] - Kolterman, O.; Insel, J.; Saekow, M.; Olefsky, J. Mechanisms of insulin resistance in human obesity: Evidence for receptor and postreceptor defects. J. Clin. Investig.
**1980**, 65, 1272–1284. [Google Scholar] [CrossRef] [PubMed] - Kolterman, O.; Gray, R.; Griffin, J.; Burstein, P.; Insel, J.; Scarlett, J.A.; Olefsky, J.M. Receptor and postreceptor defects contribute to the insulin resistance in noninsulin-dependent diabetes mellitus. J. Clin. Investig.
**1981**, 68, 957–969. [Google Scholar] [CrossRef] [PubMed] - Friedman, J.E.; Ishizuka, T.; Liu, S.; Farrell, C.J.; Bedol, D.; Koletsky, R.J.; Kaung, H.-L.; Ernsberger, P. Reduced insulin receptor signaling in the obese spontaneously hypertensive Koletsky rat. Am. J. Physiol. Endocrinol. Metab.
**1997**, 273, E1014–E1023. [Google Scholar] - Danielsson, A.; Fagerholm, S.; Öst, A.; Franck, N.; Kjolhede, P.; Nystrom, F.H.; Strålfors, P. Short-term overeating induces insulin resistance in fat cells in lean human subjects. Mol. Med.
**2009**, 15, 228–234. [Google Scholar] [CrossRef] [PubMed] - Petri, C.A. Kommunikation mit Automaten. Ph.D. Thesis, University of Bonn, Bonn, Germany, 1962. [Google Scholar]
- Murata, T. Petri nets: Properties, analysis and applications. Proc. IEEE Int. Conf. Consum. Electron.
**1989**, 77, 541–580. [Google Scholar] [CrossRef] - Koch, I.; Reisig, W.; Schreiber, F. Modeling in Systems Biology: The Petri Net Approach; Computational Biology; Dress, A., Vingron, M., Eds.; Springer-Verlag: London, UK, 2011; Volume 16. [Google Scholar]
- Reisig, W. Petri Nets: An Introduction. In EATCS Monographs on Theoretical Computer Science; Springer-Verlag: Berlin, Germany; Heidelberg, Germany, 1985; Volume 4. [Google Scholar]
- Haken, H. Synergetics. An Introduction; Springer-Verlag: Berlin, Germany; Heidelberg, Germany; New York, NY, USA, 1977. [Google Scholar]
- Murray, J.D. Mathematical Biology, 2nd ed.; Springer-Verlag: Berlin, Germany, 1993. [Google Scholar]
- Deuflhard, P.; Bornemann, F. Scientific Computing with Ordinary Differential Equations; Springer-Verlag: New York, NY, USA, 2002; Volume 42. [Google Scholar]
- Gillespie, D.T. Exact stochastic simulation of coupled chemical reactions. J. Phys. Chem.
**1977**, 81, 2340–2361. [Google Scholar] [CrossRef] - Gardiner, C.W. Handbook of Stochastic Methods; Springer-Verlag: Berlin, Germany, 1985; Volume 3. [Google Scholar]
- Wilkinson, D.J. Stochastic Modelling for Systems Biology; CRC Press: London, UK; New York, NY, USA, 2011. [Google Scholar]
- Gray, C. Sensitivity Analysis of the Insulin Signalling Pathway for Glucose Transport. Master’s Thesis, School of Mathematics and Statistics, The University of New South Wales, Pontypridd, UK, 2013. [Google Scholar]
- Gavin, J.R.; Roth, J.; Neville, D.M.; de Meyts, P.; Buell, D.N. Insulin-dependent regulation of insulin receptor concentrations: A direct demonstration in cell culture. Proc. Natl. Acad. Sci. USA
**1974**, 71, 84–88. [Google Scholar] [CrossRef] [PubMed] - Kosmakos, F.; Roth, J. Insulin-induced loss of the insulin receptor in IM-9 lymphocytes. A biological process mediated through the insulin receptor. J. Biol. Chem.
**1980**, 255, 9860–9869. [Google Scholar] [PubMed] - Kasuga, M.; Kahn, C.R.; Hedo, J.A.; van Obberghen, E.; Yamada, K.M. Insulin-induced receptor loss in cultured human lymphocytes is due to accelerated receptor degradation. Proc. Natl. Acad. Sci. USA
**1981**, 78, 6917–6921. [Google Scholar] [CrossRef] [PubMed] - Krupp, M.; Lane, M.D. On the mechanism of ligand-induced down-regulation of insulin receptor level in the liver cell. J. Biol. Chem.
**1981**, 256, 1689–1694. [Google Scholar] [PubMed] - Ronnett, G.; Knutson, V.; Lane, M. Insulin-induced down-regulation of insulin receptors in 3T3-L1 adipocytes. Altered rate of receptor inactivation. J. Biol. Chem.
**1982**, 257, 4285–4291. [Google Scholar] [PubMed] - Green, A.; Olefsky, J.M. Evidence for insulin-induced internalization and degradation of insulin receptors in rat adipocytes. Proc. Natl. Acad. Sci. USA
**1982**, 79, 427–431. [Google Scholar] [CrossRef] [PubMed] - Berhanu, P.; Olefsky, J.M.; Tsai, P.; Thamm, P.; Saunders, D.; Brandenburg, D. Internalization and molecular processing of insulin receptors in isolated rat adipocytes. Proc. Natl. Acad. Sci. USA
**1982**, 79, 4069–4073. [Google Scholar] [CrossRef] [PubMed] - Marshall, S. Kinetics of insulin receptor biosynthesis and membrane insertion: Relationship to cellular function. Diabetes
**1983**, 32, 319–325. [Google Scholar] [CrossRef] [PubMed] - Marshall, S.; Garvey, W.T.; Geller, M. Primary culture of isolated adipocytes. A new model to study insulin receptor regulation and insulin action. J. Biol. Chem.
**1984**, 259, 6376–6384. [Google Scholar] [PubMed] - Marshall, S. Kinetics of insulin receptor internalization and recycling in adipocytes. Shunting of receptors to a degradative pathway by inhibitors of recycling. J. Biol. Chem.
**1985**, 260, 4136–4144. [Google Scholar] [PubMed] - Knutson, V.; Ronnett, G.; Lane, M. The effects of cycloheximide and chloroquine on insulin receptor metabolism. Differential effects on receptor recycling and inactivation and insulin degradation. J. Biol. Chem.
**1985**, 260, 14180–14188. [Google Scholar] [PubMed] - Kahn, C.R.; White, M. The insulin receptor and the molecular mechanism of insulin action. J. Clin. Investig.
**1988**, 82, 1151–1156. [Google Scholar] [CrossRef] [PubMed] - Brunetti, A.; Maddux, B.; Wong, K.; Goldfine, I. Muscle cell differentiation is associated with increased insulin receptor biosynthesis and messenger RNA levels. J. Clin. Investig.
**1989**, 83, 192–198. [Google Scholar] [CrossRef] [PubMed] - Trischitta, V.; Wong, K.Y.; Brunetti, A.; Scalisi, R.; Vigneri, R.; Goldfine, I.D. Endocytosis, recycling, and degradation of the insulin receptor. Studies with monoclonal antireceptor antibodies that do not activate receptor kinase. J. Biol. Chem.
**1989**, 264, 5041–5046. [Google Scholar] [PubMed] - Haft, C.R.; Klausner, R.D.; Taylor, S.I. Involvement of dileucine motifs in the internalization and degradation of the insulin receptor. J. Biol. Chem.
**1994**, 269, 26286–26294. [Google Scholar] [PubMed] - Capozza, F.; Combs, T.P.; Cohen, A.W.; Cho, Y.R.; Park, S.Y.; Schubert, W.; Williams, T.M.; Brasaemle, D.L.; Jelicks, L.A.; Scherer, P.E.; et al. Caveolin-3 knockout mice show increased adiposity and whole body insulin resistance, with ligand-induced insulin receptor instability in skeletal muscle. Am. J. Physiol. Cell Physiol.
**2005**, 288, C1317–C1331. [Google Scholar] [CrossRef] [PubMed] - Ramos, F.J.; Langlais, P.R.; Hu, D.; Dong, L.Q.; Liu, F. Grb10 mediates insulin-stimulated degradation of the insulin receptor: A mechanism of negative regulation. Am. J. Physiol. Endocrinol. Metab
**2006**, 290, E1262–E1266. [Google Scholar] [CrossRef] [PubMed] - Zhou, L.; Zhang, J.; Fang, Q.; Liu, M.; Liu, X.; Jia, W.; Dong, L.Q.; Liu, F. Autophagy-mediated insulin receptor down-regulation contributes to endoplasmic reticulum stress-induced insulin resistance. Mol. Pharmacol.
**2009**, 76, 596–603. [Google Scholar] [CrossRef] [PubMed] - González-Muñoz, E.; Lopez-Iglesias, C.; Calvo, M.; Palacín, M.; Zorzano, A.; Camps, M. Caveolin-1 loss of function accelerates glucose transporter 4 and insulin receptor degradation in 3T3-L1 adipocytes. Endocrinology
**2009**, 150, 3493–3502. [Google Scholar] [CrossRef] [PubMed] [Green Version] - Mayer, C.M.; Belsham, D.D. Central insulin signaling is attenuated by long-term insulin exposure via insulin receptor substrate-1 serine phosphorylation, proteasomal degradation, and lysosomal insulin receptor degradation. Endocrinology
**2010**, 151, 75–84. [Google Scholar] [CrossRef] [PubMed] - Popova-Zeugmann, L. Time and Petri Nets: An Introduction; Springer-Verlag: Berlin, Germany; Heidelberg, Germany, 2013. [Google Scholar]
- Jensen, K. Coloured Petri Nets: Basic Concepts, Analysis Methods and Practical Use; Springer-Verlag: Berlin, Germany; Heidelberg, Germany, 1997; Volume 2. [Google Scholar]
- Ratzer, A.V.; Wells, L.; Lassen, H.M.; Laursen, M.; Qvortrup, J.F.; Stissing, M.S.; Westergaard, M.; Christensen, S.; Jensen, K. CPN tools for editing, simulating, and analysing coloured Petri nets. In Proceedings of the ICATPN’03 Proceedings of the 24th International Conference on Applications and Theory of Petri Nets, Eindhoven, The Netherlands, 23–27 June 2003; Springer-Verlag: Berlin, Germany; Heidelberg, Germany, 2003; pp. 450–462. [Google Scholar]
- Starke, P. Analyse von Petri-Netz-Modellen; G.G. Teubner-Verlag: Stuttgart, Germany, 1990. [Google Scholar]
- Balazki, P.; Lindauer, K.; Einloft, J.; Ackermann, J.; Koch, I. MonaLisa for stochastic simulations of Petri net models of biochemical systems. BMC Bioinform.
**2015**, 16, 215–226. [Google Scholar] [CrossRef] [PubMed] - Balazki, P.; Lindauer, K.; Einloft, J.; Ackermann, J.; Koch, I. Erratum to: MonaLisa for stochastic simulations of Petri net models of biochemical systems. BMC Bioinform.
**2015**, 16, 371. [Google Scholar] [CrossRef] [PubMed] - Corless, R.; Gonnet, G.; Hare, D.; Jeffrey, D.; Knuth, D. On the Lambert W function. Adv. Comput. Math.
**1996**, 5, 329–359. [Google Scholar] [CrossRef] - Lautenbach, K. Exakte Bedingungen der Lebendigkeit für eine Klasse von Petri-Netzen; Report 82; Gesellschaft für Mathematik und Datenverarbeitung: Bonn, Germany, 1973. [Google Scholar]
- Colom, J.M.; Silva, M. Convex geometry and semiflows in P/T nets. A comparative study of algorithms for computation of minimal p-semiflows. In Advances in Petri Nets; Springer-Verlag: Berlin, Germany; Heidelberg, Germany, 1991; pp. 79–112. [Google Scholar]
- Fortunato, S. Community detection in graphs. Phys. Rep.
**2010**, 486, 75–174. [Google Scholar] [CrossRef] - Shen, J.; Chen, Z.; Chen, C.; Zhu, X.; Han, Y. Impact of incretin on early-phase insulin secretion and glucose excursion. Endocrine
**2013**, 44, 403–410. [Google Scholar] [CrossRef] [PubMed] - Brunetti, A.; Manfiolett, G.; Chiefari, E.; Goldfine, I.D.; Foti, D. Transcriptional regulation of human insulin receptor gene by the high-mobility group protein HMGI (Y). FASEB J.
**2001**, 15, 492–500. [Google Scholar] [CrossRef] [PubMed] - Foti, D.; Iuliano, R.; Chiefari, E.; Brunetti, A. A nucleoprotein complex containing Sp1, C/EBP, and HMGI-Y controls human insulin receptor gene transcription. Mol. Cell. Biol.
**2003**, 23, 2720–2732. [Google Scholar] [CrossRef] [PubMed] - Puig, O.; Tjian, R. Transcriptional feedback control of insulin receptor by dFOXO/FOXO1. Genes Dev.
**2005**, 19, 2435–2446. [Google Scholar] [CrossRef] [PubMed] - Friedman, A.; Perrimon, N. A functional RNAi screen for regulators of receptor tyrosine kinase and ERK signalling. Nature
**2006**, 444, 230–234. [Google Scholar] [CrossRef] [PubMed] - Sackmann, A.; Heiner, M.; Koch, I. Application of Petri net based analysis techniques to signal transduction pathways. BMC Bioinform.
**2006**, 7, 482. [Google Scholar] [CrossRef] [PubMed] - Ackermann, J.; Einloft, J.; Nöthen, J.; Koch, I. Reduction techniques for network validation in systems biology. J. Theor. Biol.
**2012**, 315, 71–80. [Google Scholar] [CrossRef] [PubMed] - Einloft, J.; Ackermann, J.; Nöthen, J.; Koch, I. MonaLisa—Visualization and analysis of functional modules in biochemical networks. Bioinformatics
**2013**, 29, 1469–1470. [Google Scholar] [CrossRef] [PubMed] - Baumgarten, B. Petri-Netze Grundlagen und Anwendungen; Spektrum Akademischer Verlag GmbH: Heidelberg, Germany; Berlin, Germany; Oxford, UK, 1996. (In German) [Google Scholar]
- Grafahrend-Belau, E.; Schreiber, F.; Heiner, M.; Sackmann, A.; Junker, B.; Grunwald, S.; Speer, A.; Winder, K.; Koch, I. Modularization of biochemical networks based on classification of Petri Net t-invariants. BMC Bioinform.
**2008**, 9, 90. [Google Scholar] [CrossRef] [PubMed]

© 2015 by the authors; licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution license (http://creativecommons.org/licenses/by/4.0/).

## Share and Cite

**MDPI and ACS Style**

Scheidel, J.; Lindauer, K.; Ackermann, J.; Koch, I.
Quasi-Steady-State Analysis based on Structural Modules and Timed Petri Net Predict System’s Dynamics: The Life Cycle of the Insulin Receptor. *Metabolites* **2015**, *5*, 766-793.
https://doi.org/10.3390/metabo5040766

**AMA Style**

Scheidel J, Lindauer K, Ackermann J, Koch I.
Quasi-Steady-State Analysis based on Structural Modules and Timed Petri Net Predict System’s Dynamics: The Life Cycle of the Insulin Receptor. *Metabolites*. 2015; 5(4):766-793.
https://doi.org/10.3390/metabo5040766

**Chicago/Turabian Style**

Scheidel, Jennifer, Klaus Lindauer, Jörg Ackermann, and Ina Koch.
2015. "Quasi-Steady-State Analysis based on Structural Modules and Timed Petri Net Predict System’s Dynamics: The Life Cycle of the Insulin Receptor" *Metabolites* 5, no. 4: 766-793.
https://doi.org/10.3390/metabo5040766